The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?

Transforming Growth Factor-beta (TGF-β) superfamily members are essential for tissue homeostasis and consequently, dysregulation of their signaling pathways contributes to the development of human diseases. In the liver, TGF-β signaling participates in all the stages of disease progression from init...

Full description

Bibliographic Details
Main Authors: Ester Gonzalez-Sanchez, Javier Vaquero, Maite G. Férnandez-Barrena, Juan José Lasarte, Matías A. Avila, Pablo Sarobe, María Reig, Mariona Calvo, Isabel Fabregat
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
TGF-beta
TGF-beta inhibitors
HCC
HCC immunotherapy
HCC targeted therapy
Online Access:https://www.mdpi.com/2072-6694/13/13/3248

Internet

https://www.mdpi.com/2072-6694/13/13/3248

Similar Items